Literature DB >> 29181829

Long-term endurance training increases serum cathepsin S levels in healthy female subjects.

M Sponder1, C Minichsdorfer2, I-A Campean3, M Emich4, M Fritzer-Szekeres5, B Litschauer6, J Strametz-Juranek3.   

Abstract

BACKGROUND: Circulating cathepsin S (CS) has been associated with a lower risk for breast cancer in a large Swedish cohort. Long-term physical activity has been shown to have beneficial effects on the development of various cancer subtypes, in particular breast and colorectal cancers. The aim of this study was to investigate the effect of long-term endurance sport on CS levels in females.
MATERIAL AND METHODS: Thirty-six of 40 subjects completed the study. Subjects were told to increase their activity pensum for 8 months reaching 150 min/week moderate or 75 min/week intense exercise. Ergometries were performed at the beginning and the end of the study to prove/quantify the performance gain. Blood samples were drawn at baseline and every 2 months. Serum CS levels were measured by ELISA. To analyse the change and the progression of CS, Wilcoxon rank sum and Friedman tests were used.
RESULTS: The sportive group (performance gain by > 4.9%) showed a significant increase of CS levels from 3.32/2.73/4.09 to 4.00/3.09/5.04 ng/ml (p = 0.008) corresponding to an increase of 20.5%.
CONCLUSIONS: We could show a significant increase of circulating CS levels in healthy female subjects induced by long-term physical activity. CS, occurring in the tumour microenvironment, is well-known to promote tumour growth, e.g. by ameliorating angiogenesis. However, the role of circulating CS in cancer growth is not clear. As physical activity is known as preventive intervention, in particular concerning breast and colorectal cancers, and long-term physical activity leads to an increase of CS levels in female subjects, circulating CS might even be involved in this protective effect. TRIAL REGISTRATION: Clinical trial registration: NCT02097199.

Entities:  

Keywords:  Breast cancer; Cathepsin S; High-sensitivity CRP; Interleukin-6; Physical activity

Mesh:

Substances:

Year:  2017        PMID: 29181829     DOI: 10.1007/s11845-017-1693-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  29 in total

Review 1.  Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies.

Authors:  Li Liu; Yun Shi; Tingting Li; Qin Qin; Jieyun Yin; Shuo Pang; Shaofa Nie; Sheng Wei
Journal:  Br J Sports Med       Date:  2015-10-23       Impact factor: 13.800

2.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

3.  Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels.

Authors:  Michael Sponder; Ioana-Alexandra Campean; Michael Emich; Monika Fritzer-Szekeres; Brigitte Litschauer; Jutta Bergler-Klein; Senta Graf; Jeanette Strametz-Juranek
Journal:  J Sports Sci       Date:  2016-11-18       Impact factor: 3.337

4.  Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins.

Authors:  Yixuan Yang; Yang Yixuan; Shen-Kiat Lim; Lim Shen Kiat; Lee-Yee Choong; Choong Lee Yee; Huiyin Lee; Lee Huiyin; Yunhao Chen; Chen Yunhao; Poh-Kuan Chong; Chong Poh Kuan; Hassan Ashktorab; Ashktorab Hassan; Ting Ting Wang; Wang Ting Ting; Manuel Salto-Tellez; Salto-Tellez Manuel; Khay-Guan Yeoh; Yeoh Khay Guan; Yoon-Pin Lim; Lim Yoon Pin
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

5.  Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men.

Authors:  E Jobs; U Risérus; E Ingelsson; J Helmersson; E Nerpin; M Jobs; J Sundström; L Lind; A Larsson; S Basu; J Arnlöv
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

6.  Leisure-Time Spent Sitting and Site-Specific Cancer Incidence in a Large U.S. Cohort.

Authors:  Alpa V Patel; Janet S Hildebrand; Peter T Campbell; Lauren R Teras; Lynette L Craft; Marjorie L McCullough; Susan M Gapstur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-30       Impact factor: 4.254

7.  Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.

Authors:  Ramiro Vázquez; Lucile Astorgues-Xerri; Mohamed Bekradda; Julie Gormley; Richard Buick; Paul Kerr; Esteban Cvitkovic; Eric Raymond; Maurizio D'Incalci; Roberta Frapolli; María E Riveiro
Journal:  Biochimie       Date:  2014-11-05       Impact factor: 4.079

8.  Effect of long-term physical activity on PCSK9, high- and low-density lipoprotein cholesterol, and lipoprotein(a) levels: a prospective observational trial

Authors:  Michael Sponder; Ioana-Alexandra Campean; Daniel Dalos; Michael Emich; Monika Fritzer-Szekeres; Brigitte Litschauer; Jutta Bergler-Klein; Senta Graf; Jeanette Strametz-Juranek
Journal:  Pol Arch Intern Med       Date:  2017-06-09

9.  The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Authors:  J A Gormley; S M Hegarty; A O'Grady; M R Stevenson; R E Burden; H L Barrett; C J Scott; J A Johnston; R H Wilson; E W Kay; P G Johnston; S A Olwill
Journal:  Br J Cancer       Date:  2011-10-11       Impact factor: 7.640

Review 10.  Recent advances in the field of anti-cancer immunotherapy.

Authors:  Henrique Neves; Hang Fai Kwok
Journal:  BBA Clin       Date:  2015-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.